Synthesis and antimicrobial activity of new adamantane derivatives

Acta Biochimica Polonica

Volumn 47, Issue 1, 2000, Pages 87-94

  Orzeszko, Andrzej ^a   Gralewska, Renata ^b   Starościak, Bohdan J ^b   Kazimierczuk, Zygmunt ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adamantane derivatives; Antimicrobial activity; Imides

Indexed keywords

BACILLUS SP.; ENTEROCOCCUS FAECIUM; MICROCOCCUS LUTEUS; STAPHYLOCOCCUS AUREUS;

ADAMANTANE; ANTIINFECTIVE AGENT;

ARTICLE; CHEMISTRY; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

ADAMANTANE; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0033655543     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_4065     Document Type: Article

References (22)

1. Białecka-Florjańczyk, E. & Orzeszko, A. (1993) Some novel liquid crystalline derivatives of 4-carboxyphthalimide. Liq. Cryst. 15, 255-258.
2. Białecka-Florjańczyk, E., Orzeszko, A. & Śledzińska, I. (1997) Cholesteryl ester imides with oxyethylene and methylene tails. Mol. Cryst. Liq. Cryst. 300, 1-8.
3. Białecka-Florjańczyk, E., Orzeszko, A., Śledzinska, I. & Górecka, E. (1999) Evidence of the smectic antiphase in 4-decyloxybiphenyl ester imide derivatives. J. Mater. Chem. 9, 371-374.
4. Śledzińska, I., Białecka-Florjańczyk, E. & Orzeszko, A. (1996) Synthesis and liquid crystalline properties of cholesteryl bisester imides with poly(ethylene oxide)s as central spacer. Eur. Polym. J. 32, 1345-1350.
5. Kricheldorf, H.R. (1999) Liquid-crystalline polyimides. Adv. Polym. Sci. 141, 84-188.
6. Loncrini, D.F. (1966) Aromatic poly(ester imide)s. J. Polym. Sci. Part A-1. 4, 1531-1541.
7. Kricheldorf, H.R. (1994) Liquid-crystalline polyimides. Mol. Cryst. Liq. Cryst. 254, 87-108.
8. Kricheldorf, H.R. & Pakull, R. (1988) New polymer synthesis. 20. Liquid-crystalline poly(ester imide)s derived from trimellitic anhydride, α,ω-diaminoalkanes and 4,4′-dihydroxybiphenyl. Macromolecules 21, 551-557.
9. Mallawaarachchi, W., Simmonds, R.J. & Parry, D.E. (1989) The geometry of N-hydroxymethyl compounds. Part 3: Geometries of N-(hydroxymethyl)amides related to reactivities. Anti-Cancer Drug Des. 4, 233-240.
10. Davies, W.L., Grunert, R.R., Haff, R.F., McGahen, J.W., Neumayer, E.M., Paulshock, M., Watts, J.C., Wood, T.R., Hermann, E.C. & Hoffmann, C.E. (1964) Antiviral activity of 1-adamantanamine (amantidine). Science 144, 862-863.
11. Schwab, R.S., England, A.C., Jr., Poskanzer, D.C. & Young, R.R. (1969). Amantadine in the treatment of Parkinson's disease. J. Am. Med. Assoc. 208, 1168-1170.
12. Płachta, D. & Starościak, B. (1994) Synthesis of some 1-alkylamino-2,4-adamantylphenoxy)ethane derivatives. Acta Polon. Pharm. 51, 51-54.
13. Papadaki-Valiraki, A., Papakonstantinou-Garoufalias, S., Makaros, P., Chytyroglou-Lada, A., Hosoya, M., Balzarini, J. & De Clercq, E. (1993) Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers. Il Farmaco 48, 1091-1102.
14. Wang, J.-J., Wang, S.-S., Lee, Ch.-F., Chung, M.-A. & Chern, Y.-T. (1997; In vitro antitumor and antimicrobial activities of N-substituts of maleimide by adamantane and diamantane. Chemotherapy 43, 182-189.
15. Takatori, Y. (1992) N-1-adamantylmaleimide. Jpn. Kokai Tokyo Koho, Japan Pat. 6028961.
16. Sabata, Y., Shichita, M., Sasaki, K., Hashimoto, Y. & Iwasaki, S. (1995) N-Alkylphthalimides: Structural requirement of thalidomidal action on 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor α production by human leukemia HL-60 cells. Chem. Pharm. Bull. 43, 177-179.
17. National Committee for Clinical Laboratory Standards NCCLS Approved Standard Document M7-A. (1985) Villanova, PA, U.S.A.
18. National Committee for Clinical Laboratory Standards 5th edn. Approved Standard NCCLS Document M2-A5. (1993) Villanova, PA, U.S.A.
19. Białecka-Florjańczyk, E. & Orzeszko, A. (1999) Sposób wytwarzania ciekłokrystalicznego bezwodnika 4-cholesteryloksykarbonyloftalowego. Pol. Patent 175659 (in Polish).
20. Białecka-Florjańczyk, E. & Orzeszko, A. (1999) Sposób wytwarzania ciekłokrystalicznych estrów cholesterolowych pochodnych bezwodnika 4-cholesteryloksykarbonyloftalo-wego. Pol. Patent 176084 (in Polish).
21. Kalodera, Z., Popejnak, S., Blazevic, N., Petrak, T. (1997) Chemical composition and antimicrobial activity of Tanacetum parthenium essential oil. Pharmazie 52, 885-886.
22. Kada, T., Hirano, K. & Shirazu, Y. (1980) Screening of environmental chemical mutagens by the rec-assay system with Bacillus subtilis. Chemical Mutagens (de Serres, F.J. & Hollaender, A., eds.) vol. 6, pp. 149-173, Plenum Pub. Co., New York.